Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis.

@article{Lee2001ManagementOF,
  title={Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis.},
  author={Grace Soyon Lee and Gary R. Fleisher and Marvin B. Harper},
  journal={Pediatrics},
  year={2001},
  volume={108 4},
  pages={835-44}
}
OBJECTIVES The optimal practice management of highly febrile 3- to 36-month-old children without a focal source has been controversial. The recent release of a conjugate pneumococcal vaccine may reduce the rate of occult bacteremia and alter the utility of empiric testing and treatment. The objective of this study was to determine the cost-effectiveness of 6 different management strategies of febrile 3- to 36-month-old children at current and declining rates of occult pneumococcal bacteremia… CONTINUE READING